Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
News
Panel weighs in on the changing face of oncology
Publish date:
April 1, 2011
This shift in costs to patients is not a problem for most minor ailments, Mr. Okon said, but it is another matter entirely when it comes to cancer.
None of the panelists had any conflicts of interest to disclose.
Pages
« first
1
2
3
Recommended Reading
MedPAC Ponders SGR Alternatives
MDedge Hematology and Oncology
Research Groups Ally as NCI Clinical Trials Program Begins Seismic Shift
MDedge Hematology and Oncology
Accountable Care Organizations Take Shape
MDedge Hematology and Oncology
Practice Management
Business of Medicine
All Specialties